Indian drugmaker Zydus Lifesciences reported a 14% rise in second-quarter profit on Tuesday, helped by strong demand for generic drugs in its key United States and Indian markets.

Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.

Buyout firm Advent International is considering the sale of generic drugmaker Zentiva, in a deal that could value the former Sanofi unit at about €5 billion ($5.4 billion), according to people ...

Emily Odio-Sutton started a side hustle in December 2022. She used print-on-demand services to create personalized products.

In today’s fast-paced, automated world, where generic solutions are often marketed as universally applicable and customer ...

On the verge of a forthcoming expansion to the U.S., Avantia CEO and founder James Sutton describes its offerings and its ...

citing three people familiar with the matter. The New York-based pharma giant established Pfizer Hospital after combining its ...

Wells Fargo chief agricultural economist Michael Swanson and his team put together a typical Thanksgiving meal for ten people ...

American Vanguard Corporation (NYSE: AVD) Q3 2024 Earnings Call Transcript November 11, 2024 ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

This is one person's ultimate Ireland bucket list - from the surf up North to going on a ghost hunt. What would be on your ...